Qualigen Therapeutics down after reverse stock split plan
** Shares of biotech company Qualigen Therapeutics Inc
QLGN.O fall ~5% to 19 cents
** Co announces a 1-for-10 reverse stock split of the co's
common stock
** Implementing the reverse stock split to enable co to
regain compliance with Nasdaq's minimum bid price requirement -
QLGN
** QLGN shares to begin trading on a split-adjusted basis at
market open on Nov. 23
** Including session moves, stock down ~82% YTD
(Reporting by Raghav Mahobe)
((Raghav.Mahobe@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise